logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 7125903 B1

PDFFull Text
Expired
Date of Patent:
Oct. 24, 2006

Filed:

Sep. 13, 2000

[object object]

Applicants:

David M. Fink, Lebanon, NJ (US);

Brian S. Freed, Phillipsburg, NJ (US);

Nicholas J. Hrib, Hillsborough, NJ (US);

Raymond W. Kosley, Jr., Bridgewater, NJ (US);

George E. Lee, Somerville, NJ (US);

Gregory H. Merriman, Phillipsburg, NJ (US);

Barbara S. Rauckman, Flemington, NJ (US);

Inventors:

David M. Fink, Lebanon, NJ (US);

Brian S. Freed, Phillipsburg, NJ (US);

Nicholas J. Hrib, Hillsborough, NJ (US);

Raymond W. Kosley, Jr., Bridgewater, NJ (US);

George E. Lee, Somerville, NJ (US);

Gregory H. Merriman, Phillipsburg, NJ (US);

Barbara S. Rauckman, Flemington, NJ (US);

Assignee:

Aventis Pharmaceuticals Inc., Bridgewater, NJ (US);

Attorney:

Barbara E. Kurys

Primary Examiner:

Golam M M Shameem

Int. Cl.
CPC ...
A61K 31/42 (2006.01); A61K 31/415 (2006.01); C07D 261/00 (2006.01); C07D 231/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

The compounds are of the class thienoisoxazolyl- and thienylpyrrazolyl-phenoxy substituted propyl derivatives, useful as Dantagonists. Said compounds are useful for the treatment of medical conditions mediated by inhibition of Dreceptor. These conditions comprise, for example, Attention Deficit Hyperactivity Disorder, Obsessive-Compulsive Disorder, Psychoses, Substance Abuse, Substance Dependence, Parkinson's Disease, Parkinsonism, Tardive Diskinesia, Gilles de la Tourette Syndrome, Conduct Disorder, and Oppositional Defiant Disorder. A further aspect of the invention is to provide a pharmaceutical composition, intermediates, and a method of making said class of compounds.

Find Patent Forward Citations

Fink, David. (2006). [object object] (U.S. Patent No. 7125903). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/7125903

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…